Ignite Creation Date:
2024-05-06 @ 5:59 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05501886
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2022-08-12
Brief Title:
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HRHER2- Breast Cancer VIKTORIA-1
Sponsor:
Organization:
Celcuity Inc